Last10K.com

Biosig Technologies, Inc. (BSGM) SEC Filing 10-Q Quarterly Report for the period ending Thursday, March 31, 2022

SEC Filings

BSGM Quarterly Reports

Biosig Technologies, Inc.

CIK: 1530766 Ticker: BSGM
Document And Entity Information - shares
3 Months Ended
Mar. 31, 2022
May 16, 2022
Document Information Line Items  
Entity Registrant NameBIOSIG TECHNOLOGIES, INC. 
Trading SymbolBSGM 
Document Type10-Q 
Current Fiscal Year End Date--12-31 
Entity Common Stock, Shares Outstanding 39,611,559
Amendment Flagfalse 
Entity Central Index Key0001530766 
Entity Current Reporting StatusYes 
Entity Filer CategoryNon-accelerated Filer 
Document Period End DateMar. 31, 2022 
Document Fiscal Year Focus2022 
Document Fiscal Period FocusQ1 
Entity Small Businesstrue 
Entity Emerging Growth Companyfalse 
Entity Shell Companyfalse 
Document Quarterly Reporttrue 
Document Transition Reportfalse 
Entity File Number001-38659 
Entity Incorporation, State or Country CodeDE 
Entity Tax Identification Number26-4333375 
Entity Address, Address Line One55 Greens Farms Road, 1st Floor 
Entity Address, City or TownWestport 
Entity Address, State or ProvinceCT 
Entity Address, Postal Zip Code06880 
City Area Code203 
Local Phone Number409-5444 
Title of 12(b) SecurityCommon Stock, par value $0.001 per share 
Security Exchange NameNASDAQ 
Entity Interactive Data CurrentYes 

View differences made from one quarter to another to evaluate Biosig Technologies, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Biosig Technologies, Inc..

Continue

Assess how Biosig Technologies, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Biosig Technologies, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Rating

Learn More
Bullish Bearish Neutral
Filter Sentiment:
All
Positive
Negative
Filter Category:
All
Financial
Revenue
Other
Filter Subcategory:
All
Expense
Product
Cash Flow
Shares
Other
Inside Biosig Technologies, Inc.'s 10-Q Quarterly Report:

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parentheticals)
Consolidated Statement Of Stockholders' Equity (Deficit)
Consolidated Statement Of Stockholders' Equity (Deficit) (Parentheticals)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Accounting Policies, By Policy (Policies)
Accounts Payable And Accrued Expenses
Accounts Payable And Accrued Expenses (Details) - Schedule Of Accounts Payable And Accrued Liabilities
Accounts Payable And Accrued Expenses (Tables)
Commitments And Contingencies
Commitments And Contingencies (Details)
Going Concern And Management's Liquidity Plans
Going Concern And Management's Liquidity Plans (Details)
Nature Of Operations And Basis Of Presentation
Nature Of Operations And Basis Of Presentation (Details)
Non-Controlling Interest
Non-Controlling Interest (Details)
Non-Controlling Interest (Details) - Consolidation, Less Than Wholly Owned Subsidiary, Parent Ownership Interest, Effects Of Changes, Net
Non-Controlling Interest (Details) - Schedule Of Non-Controlling Interest
Non-Controlling Interest (Tables)
Options, Restricted Stock Units And Warrants
Options, Restricted Stock Units And Warrants (Details)
Options, Restricted Stock Units And Warrants (Details) - Nonvested Restricted Stock Shares Activity
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Share-Based Compensation, Shares Authorized Under Stock Option Plans, By Exercise Price Range
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Share-Based Compensation, Stock Options, Activity
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Share-Based Payment Award, Stock Options, Valuation Assumptions
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Stockholders' Equity Note, Warrants Or Rights
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Warrants Or Rights, Shares Authorized, By Exercise Price Range
Options, Restricted Stock Units And Warrants (Details) - Schedule Of Warrants Or Rights, Shares Authorized, Exercise Price Range
Options, Restricted Stock Units And Warrants (Tables)
Property And Equipment
Property And Equipment (Details) - Schedule Of Property, Plant And Equipment
Property And Equipment (Details)
Property And Equipment (Tables)
Related Party Transactions
Related Party Transactions (Details)
Right To Use Assets And Lease Liability
Right To Use Assets And Lease Liability (Details)
Right To Use Assets And Lease Liability (Details) - Lease, Cost
Right To Use Assets And Lease Liability (Details) - Lease, Cost
Right To Use Assets And Lease Liability (Details) - Lessee, Operating Lease, Liability, Maturity
Right To Use Assets And Lease Liability (Details) - Right To Use Asset
Right To Use Assets And Lease Liability (Tables)
Segment Reporting
Segment Reporting (Details) - Schedule Of Segment Reporting Information, By Segment
Segment Reporting (Tables)
Stockholder Equity
Stockholder Equity (Details)
Subsequent Events
Subsequent Events (Details)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Details)
Summary Of Significant Accounting Policies (Details) - Deferred Revenue, By Arrangement, Disclosure
Summary Of Significant Accounting Policies (Details) - Disaggregation Of Revenue
Summary Of Significant Accounting Policies (Details) - Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share
Summary Of Significant Accounting Policies (Details) - Schedule Of Inventory, Current
Summary Of Significant Accounting Policies (Tables)

Material Contracts, Statements, Certifications & more

Biosig Technologies, Inc. provided additional information to their SEC Filing as exhibits

Ticker: BSGM
CIK: 1530766
Form Type: 10-Q Quarterly Report
Accession Number: 0001185185-22-000641
Submitted to the SEC: Mon May 16 2022 4:03:30 PM EST
Accepted by the SEC: Mon May 16 2022
Period: Thursday, March 31, 2022
Industry: Electromedical And Electrotherapeutic Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/bsgm/0001185185-22-000641.htm